SOD2 and neoplasm: In the tumor tissues obtained from the MKN45 cell xenograft model, the tEx(D) treatment led to the most substantial reduction in the expressions of the antioxidant enzymes SOD2 and catalase (p < 0.05) (Figure 7A).